Introduction of Dedicated CPT Codes for SRT
CMS published first-ever dedicated CPT codes for superficial radiotherapy (SRT) in nonmelanoma, skin cancer, and keloids, increasing reimbursement per fraction by more than 300%.
Strong Growth in Treatment Volumes
FDA treatment volumes increased 20% from the second quarter and 52% compared to the first quarter, with a 157% increase since the program's launch.
Solid Cash Position
Sensus Healthcare ended the quarter with $24.5 million in cash, up from approximately $22 million at the end of 2024, driven by improved working capital management.
International Expansion Efforts
Shipped 3 SRT systems to China and made progress with international expansion into markets like Canada, Brazil, Japan, and Australia with MDSAP certification.